4.4 Article

Modeling the Value for Money of Changing Clinical Practice Change A Stochastic Application in Diabetes Care

Journal

MEDICAL CARE
Volume 47, Issue 10, Pages 1053-1061

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MLR.0b013e31819e1f2b

Keywords

health economics; implementation research; decision analysis; stochastic models; decision making

Ask authors/readers for more resources

Background: Decision making about resource allocation for guideline implementation to change clinical practice is inevitably undertaken in a context of uncertainty surrounding the cost-effectiveness of both clinical guidelines and implementation strategies. Adopting a total net benefit approach, a model was recently developed to overcome problems with the use of combined ratio statistics when analyzing decision uncertainty. Objective: To demonstrate the stochastic application of the model for informing decision making about the adoption of an audit and feedback strategy for implementing a guideline recommending intensive blood glucose control in type 2 diabetes in primary care in the Netherlands. Methods: An integrated Bayesian approach to decision modeling and evidence synthesis is adopted, using Markov Chain Monte Carlo simulation in WinBUGs. Data on model parameters is gathered from various sources, with effectiveness of implementation being estimated using pooled, random-effects meta-analysis. Decision uncertainty is illustrated using cost-effectiveness acceptability curves and frontier. Results: Decisions about whether to adopt intensified glycemic control and whether to adopt audit and feedback alter for the maximum values that decision makers are willing to pay for health gain. Through simultaneously incorporating uncertain economic evidence on both guidance and implementation strategy, the cost-effectiveness acceptability curves and cost-effectiveness acceptability frontier show an increase in decision uncertainty concerning guideline implementation. Conclusions: The stochastic application in diabetes care demonstrates that the model provides a simple and useful tool for quantifying and exploring the (combined) uncertainty associated with decision making about adopting guidelines and implementation strategies and, therefore, for informing decisions about efficient resource allocation to change clinical practice. Key Words: health economics, implementation research, decision analysis, stochastic models, decision making

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Economics

Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUM

Irina Pokhilenko, Luca M. M. Janssen, Aggie T. G. Paulus, Ruben M. W. A. Drost, William Hollingworth, Joanna C. Thorn, Sian Noble, Judit Simon, Claudia Fischer, Susanne Mayer, Luis Salvador-Carulla, Alexander Konnopka, Leona Hakkaart van Roijen, Valentin Brodszky, A-La Park, Silvia M. A. A. Evers

Summary: This study provides a detailed description of the practical application of a stepwise approach to the development of a multi-sectoral Resource Use Measurement (RUM) instrument. It highlights the need for additional steps to ensure a uniform methodological basis, harmonization of questionnaire modules, and involvement of a broader range of stakeholders due to the complexity of developing a multi-sectoral RUM instrument.

APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2023)

Article Medicine, Research & Experimental

The effectiveness and health-economic evaluation of Partner in Balance, a blended self-management program for early-stage dementia caregivers: study protocol for a cluster-randomized controlled trial

Sander L. Osstyn, Ron Handels, Lizzy M. M. Boots, Sanne C. E. Balvert, Silvia M. A. A. Evers, Marjolein E. de Vugt

Summary: This paper presents the design of a study evaluating the effectiveness, cost-effectiveness, and cost-utility of a blended self-management program for early-stage dementia caregivers. The study will be a pragmatic, cluster randomized controlled trial with a shared control group. The primary outcome for effectiveness is care management self-efficacy.

TRIALS (2023)

Review Cardiac & Cardiovascular Systems

A systematic literature review of economic evaluations and cost-of-illness studies of inherited cardiomyopathies

Isabell Wiethoff, Birgit Goversen, Michelle Michels, Jolanda van der Velden, Mickael Hiligsmann, Tom Kugener, Silvia M. A. A. Evers

Summary: This study systematically identified and reviewed cost-of-illness (COI) studies and economic evaluations (EEs) of hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). The results showed that these inherited heart conditions have a significant societal and economic burden, but current knowledge is limited. Future research should consider a broader range of costs to optimize care for affected patients.

NETHERLANDS HEART JOURNAL (2023)

Review Cardiac & Cardiovascular Systems

An introduction to health technology assessment and health economic evaluation: an online self-learning course

Isabell Wiethoff, Silvia M. A. A. Evers, Michelle Michels, Mickael Hiligsmann

Summary: Cardiovascular diseases impose a significant burden on patients and society. The Netherlands is increasingly using health technology assessment (HTA) to inform policy bodies and guide decision-making on healthcare funding. This paper aims to define HTA, discuss its relevance to healthcare policy, and provide an overview of economic evaluation methodology targeting health professionals and researchers with limited prior knowledge.

NETHERLANDS HEART JOURNAL (2023)

Article Endocrinology & Metabolism

PHQ-9, CES-D, health insurance data-who is identified with depression? A Population-based study in persons with diabetes

Ute Linnenkamp, Veronika Gontscharuk, Katherine Ogurtsova, Manuela Bruene, Nadezda Chernyak, Tatjana Kvitkina, Werner Arend, Imke Schmitz-Losem, Johannes Kruse, Norbert Hermanns, Bernd Kulzer, Silvia M. A. A. Evers, Mickael Hiligsmann, Barbara Hoffmann, Andrea Icks, Silke Andrich

Summary: This study examined how different instruments identify depression among patients with diabetes and found that the choice of method is related to specific characteristics such as gender, antidepressant use, and previous depression.

DIABETOLOGY & METABOLIC SYNDROME (2023)

Review Medicine, General & Internal

Methodology of economic evaluations in spine surgery: a systematic review and qualitative assessment

Ruud Droeghaag, Valerie N. E. Schuermans, Sem M. M. Hermans, Anouk Y. J. M. Smeets, Inge J. M. H. Caelers, Mickael Hiligsmann, Silvia Evers, Wouter L. W. van Hemert, Henk van Santbrink

Summary: This systematic review aims to evaluate the methodology and quality of clinical cost-effectiveness studies in spine surgery. The study found that there is a lack of comparability among existing economic evaluations in spine surgery, highlighting the need for uniformity in conducting and reporting such evaluations.

BMJ OPEN (2023)

Article Health Care Sciences & Services

The societal costs of multiple sclerosis in Lebanon: a cross-sectional study

Jalal Dahham, Mickael Hiligsmann, Ingrid Kremer, Samia J. Khoury, Hala Darwish, Hassan Hosseini, Silvia Evers, Rana Rizk

Summary: This study assessed the societal costs of multiple sclerosis (MS) in Lebanon, categorized by disease severity. The study revealed a significant economic burden of MS on the Lebanese healthcare system and society.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2023)

Article Economics

Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease

Francis Shupo, Keith R. Abrams, Zanfina Ademi, Grace Wayi-Wayi, Natasa Zibelnik, Matt Kirchmann, Carolyn Rutherford, Kelly Makarounas-Kirchmann

Summary: This paper presents an Australian model for the assessment of the cost-effectiveness of siltuximab for idiopathic Multicentric Castleman Disease (iMCD) in Australia. The model was informed by literature reviews, clinical trial data, and stakeholder input, and estimated an incremental cost-effectiveness ratio of A$84,935 per quality-adjusted life-year (QALY) gained. The results suggest that siltuximab has a 72.1% probability of being cost-effective compared with placebo and best supportive care at a willingness-to-pay threshold of A$100,000 per QALY.

PHARMACOECONOMICS-OPEN (2023)

Article Psychiatry

Trial-based economic evaluation of mindfulness-based cognitive therapy compared to treatment as usual for bipolar disorder

Ben Wijnen, Maud Jansen, Annelieke van Velthoven, Imke Hanssen, Marloes Huijbers, Silvia Evers, Anne Speckens

Summary: The cost-effectiveness and cost-utility of mindfulness-based cognitive therapy (MBCT) and treatment as usual (TAU) were assessed in adults with Bipolar disorder (BD) compared to TAU alone. The study found that MBCT + TAU had lower total costs and only significant differences in healthcare costs compared to TAU. Furthermore, MBCT + TAU showed small differences in QALYs and costs, resulting in a dominant incremental cost-utility ratio. Sensitivity analyses confirmed the robustness of the base case analyses.

INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2023)

Article Cardiac & Cardiovascular Systems

Quality of life and societal costs in patients with dilated cardiomyopathy

Isabell Wiethoff, Maurits Sikking, Silvia Evers, Andrea Gabrio, Michiel Henkens, Michelle Michels, Job Verdonschot, Stephane Heymans, Mickael Hiligsmann

Summary: Dilated cardiomyopathy (DCM) is a major cause of heart failure, leading to low quality of life and high societal costs for patients, especially those with severe symptoms.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2023)

Article Psychology, Multidisciplinary

An investigation of age dependency in Dutch and Chinese values for EQ-5D-Y

Brigitte Essers, Pei Wang, Elly Stolk, Marcel F. Jonker, Silvia Evers, Manuela Joore, Carmen Dirksen

Summary: The study aimed to explore the age dependency of health state values derived from trade-offs between HRQoL and life years, and found differences in consistency of health state values for different age groups between the Netherlands and China, as well as no clear patterns in the composition of QALYs.

FRONTIERS IN PSYCHOLOGY (2023)

Article Health Care Sciences & Services

Expert opinion on a consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies: qualitative interviews

Lena Schnitzler, Aggie T. G. Paulus, Silvia M. A. A. Evers, Tracy E. Roberts, Louise J. Jackson

Summary: The study sought experts' views on the development of a checklist for cost-of-illness (COI) studies. Interviews with 21 experts from 11 countries confirmed the relevance of COI studies in estimating disease burden, identifying cost components, guiding decision making, and providing input for economic evaluations. A lack of standardized critical appraisal tools for COI studies was mentioned, with experts primarily relying on guidelines and checklists for full economic evaluations. Themes discussed during the interviews included the need for a critical appraisal tool, format and practicality, assessing questions, addressing subjectivity, and guidance requirements.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2023)

Article Health Care Sciences & Services

Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe

Damon Willems, Eva-Lotta Hinzpeter, Hessel H. Van der Zee, Christopher J. Sayed, John R. Ingram, Charlotte Beaudart, Silvia M. A. A. Evers, Mickael Hiligsmann

Summary: This study investigated the treatment preferences of adult patients with HS in Europe. The results revealed that effectiveness was the most important attribute, followed by pain reduction, risk of mild adverse events, risk of serious infection, mode of administration, and duration of treatment benefit. Future HS treatments should be designed to offer higher levels of effectiveness and pain improvement without increasing the risk of adverse events.

PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2023)

Article Pediatrics

Parental measurement of height in growth hormone-treated children in the hospital setting proves valid: an observational study - potential for replacement of outpatient clinic visits to the home setting

Anouk J. W. Remmits, Ghislaine A. P. G. van Mastrigt, Silvia M. A. A. Evers, Hedi L. Claahsen-van Der Grinten, Petra A. van Setten

Summary: Reliable height measurement is crucial for assessing the effectiveness of costly growth hormone therapy. This observational study found a strong correlation between parentally performed height measurements and measurements in the outpatient setting, with only a minor underestimation observed.

EUROPEAN JOURNAL OF PEDIATRICS (2023)

Article Health Care Sciences & Services

A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies

Lena Schnitzler, Tracy E. Roberts, Louise J. Jackson, Aggie T. G. Paulus, Silvia M. A. A. Evers

Summary: The objective of this study was to develop a consensus-based checklist for the critical appraisal of cost-of-illness studies. The checklist, comprising seventeen main questions, aims to improve comprehensiveness, transparency, and consistency in these studies. The study also developed guidance statements explaining each question and suggested answer categories to ensure better comparability across international studies.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2023)

No Data Available